Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
News Mar 22, 2013
The objectives and goals of the Southern Swedish Malignant Melanoma (SSMM) are to develop, build and utilize cutting edge biobanks and OMICS platforms to better understand disease pathology and drug mechanisms. The SSMM research team is a truly cross-functional group with members from oncology, surgery, bioinformatics, proteomics, and genomics initiatives. Within the research team there are members who daily diagnose patients with suspect melanomas, do follow-ups on malignant melanoma patients and remove primary or metastatic lesions by surgery. This inter-disciplinary clinical patient care ensures a competence build as well as a best practice procedure where the patient benefits.
This article was published online in Clinical and Translational Medicine, and is free to access.
Bioenergetic Changes Seen in Stem Cells from Late Onset Alzheimer's Disease PatientsNews
Researchers find bioenergetic abnormalities may be an inherent mechanism underlying Late Onset Alzheimer's DiseaseREAD MORE
Nobel Prize for Chemistry 2017 Honors a Cool Revolution in BiochemistryNews
Cryo-EM allows the study of biomolecules at atomic resolution prepared under cryogenic conditions.READ MORE